Cargando…
No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache
Headache is one of the most common neurological manifestations of COVID-19, but it is unclear whether chronic headache as a symptom of Post-COVID-19 is associated with ongoing CNS damage. We compared cerebrospinal fluid (CSF) levels of markers of CNS damage and inflammation in Post-COVID-19 patients...
Autores principales: | de Boni, Laura, Odainic, Alexandru, Gancarczyk, Natalie, Kaluza, Luisa, Strassburg, Christian P., Kersting, Xenia A. K., Wüllner, Ullrich, Schmidt, Susanne V., Petzold, Gabor C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536703/ https://www.ncbi.nlm.nih.gov/pubmed/37759276 http://dx.doi.org/10.1186/s42466-023-00277-1 |
Ejemplares similares
-
No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache
por: de Boni, Laura, et al.
Publicado: (2022) -
Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
por: de Boni, Laura, et al.
Publicado: (2019) -
Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans
por: Striepens, Nadine, et al.
Publicado: (2013) -
High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression
por: Stahl, Fabian, et al.
Publicado: (2023) -
Headache due to Spontaneous Spinal Cerebrospinal Fluid Leaks
por: Fujiwara, Michimasa, et al.
Publicado: (2018)